BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 78 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,654 | -20.6% | 4,593 | -6.0% | 0.00% | -25.0% |
| Q2 2023 | $80,196 | -26.8% | 4,884 | -27.2% | 0.00% | -33.3% |
| Q1 2023 | $109,553 | -2.8% | 6,709 | -8.1% | 0.01% | -25.0% |
| Q4 2022 | $112,696 | -10.6% | 7,304 | -9.3% | 0.01% | -20.0% |
| Q3 2022 | $126,000 | -20.3% | 8,052 | -16.4% | 0.01% | -23.1% |
| Q2 2022 | $158,000 | +12.9% | 9,635 | +10.2% | 0.01% | +18.2% |
| Q1 2022 | $140,000 | -55.7% | 8,740 | -25.3% | 0.01% | -64.5% |
| Q3 2021 | $316,000 | -2.2% | 11,695 | +4.6% | 0.03% | -6.1% |
| Q2 2021 | $323,000 | +14.9% | 11,178 | +4.6% | 0.03% | 0.0% |
| Q1 2021 | $281,000 | +33.8% | 10,690 | +46.0% | 0.03% | +26.9% |
| Q4 2020 | $210,000 | +218.2% | 7,321 | +162.7% | 0.03% | +160.0% |
| Q3 2020 | $66,000 | +1220.0% | 2,787 | +1014.8% | 0.01% | +900.0% |
| Q2 2020 | $5,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |